永新光学(603297):Q3业绩符合预期,高端显微镜持续放量

Investment Rating - The investment rating for the company is "Accumulate" (maintained) [1] Core Views - The company reported Q3 results that met expectations, with high-end microscope sales continuing to grow [4] - For the first three quarters of 2025, the company achieved revenue of 674 million yuan, a year-on-year increase of 3.59%, and a net profit attributable to shareholders of 151 million yuan, up 7.69% year-on-year [4] - The gross margin for the first three quarters reached 40.32%, an increase of 1.25 percentage points year-on-year, while the net profit margin was 22.39%, up 0.91 percentage points year-on-year [4] Summary by Sections Financial Performance - In Q3 2025, the company achieved revenue of 233 million yuan, a year-on-year increase of 4.81% and a quarter-on-quarter increase of 5.27% [4] - The net profit attributable to shareholders for Q3 was 43 million yuan, a year-on-year increase of 5.08% but a quarter-on-quarter decrease of 18.83% [4] - The non-recurring net profit reached 39 million yuan, a year-on-year increase of 17.57% and a quarter-on-quarter decrease of 9.66% [4] Business Segments - The microscope business is a focal point, with high-end microscopes experiencing rapid growth, accounting for over 40% of total microscope sales [5] - The company is expected to benefit from accelerated procurement of high-end microscopes by universities and research institutions due to supportive national policies [5] - The machine vision business also showed robust growth, with double-digit increases in H1 2025, and the company is expanding into new applications such as iris recognition for virtual currency terminals [6] Future Projections - Revenue projections for 2025-2027 are 1.003 billion yuan, 1.328 billion yuan, and 1.761 billion yuan respectively, with corresponding net profits of 254 million yuan, 358 million yuan, and 495 million yuan [7] - The expected EPS for the same period is 2.29 yuan, 3.22 yuan, and 4.46 yuan, with P/E ratios of 38.05x, 27.03x, and 19.54x respectively [7]